in a news release, the drug's manufacturer, amgen, said the list price will be 5 a month or ,900 annually. costs to patients may vary depending on insurance..

erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the.

the medical experts are worse. their pretense of idealism knows no limits, and is matched only by their claim to bullet-proof knowledge..

. 18 hours ago.

. february 2011  (34).

executive director of saen michael budkie made these reports public in a letter addressed to chancellor carol christ on wednesday. march 2006  (22)..